Access cutting-edge von hippel-lindau disease treatment through this clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Detroit location
Preparing your pre-screening questions…
Access von hippel-lindau disease specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related von hippel-lindau disease treatment provided free
Check if you qualify for this von hippel-lindau disease clinical trial in Detroit, MI
No-Cost Study Care
Local to Detroit
Convenient for MI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Researchers are looking for new ways to treat advanced solid tumors and von Hippel-Lindau (VHL)-related tumors: * Advanced means the cancer has spread to other parts of the body (metastatic) or cannot be removed with surgery * Solid tumors are cancers mostly in body organs and tissues, not in the blood or other body liquids * VHL-related tumors are tumors caused by VHL disease. VHL disease is passed down from parents to children and people with VHL disease have a higher chance of getting certain types of cancer Researchers want to learn about the long-term effects of a trial medicine called belzutifan. Belzutifan, also called MK-6482, is designed to block a protein that helps tumors grow and survive. This is an extension trial, which means only people who were in certain other belzutifan trials (called parent trials) may be able to join. The goal of this trial is to learn how long people live after they start taking belzutifan.
Sponsor: Merck Sharp & Dohme LLC
Yes, this clinical trial (NCT07405164) has an active research site in Detroit, MI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for von hippel-lindau disease treatment options in Detroit, MI, this clinical trial (NCT07405164) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Detroit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced von hippel-lindau disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all von hippel-lindau disease clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Detroit — not just this study.
Browse Pulmonary Embolism Trials in Detroit →